Stockreport

ArriVent Announces a Multi-Target ADC Collaboration with Alphamab [Yahoo! Finance]

ArriVent BioPharma, Inc.  (AVBP) 
PDF Upfront and milestone payments to Alphamab worth up to $615.5 million for potential ADCs SUZHOU, China and NEWTOWN SQUARE, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- Arri [Read more]